INFINITY PHARMACEUTICALS, INC. (12)

Browse by Contract Category

Contracts

Description of Securities Registered Under Section 12 of the Exchange Act (Filed With SEC on March 3, 2020)
Funding Agreement, dated January 8, 2020, by and among Infinity Pharmaceuticals, Inc., BVF Partners, L.P., and Royalty Security, LLC (Filed With SEC on March 3, 2020)
Form of Stock Option Agreement under 2019 Equity Incentive Plan (Filed With SEC on July 30, 2019)
Amended and Restated Capital on Demand Sales Agreement, dated July 29, 2019, by and among Infinity Pharmaceuticals, Inc. and JonesTrading Institutional Services LLC and B. Riley... (Filed With SEC on July 30, 2019)
Amendment No. 4 to Amended and Restated Development and License Agreement, dated as of March 4, 2019, by and between the Registrant and Intellikine LLC (Filed With SEC on May 7, 2019)
Lease Agreement, dated April 3, 2019, between Registrant and Sun Life Assurance Company of Canada (Filed With SEC on May 7, 2019)
Novation and Amendment Agreement, dated January 27, 2020, by and among Infinity Pharmaceuticals, Inc., BVF Partners, L.P., Royalty Security, LLC, and Royalty Security Holdings, LLC (Filed With SEC on March 3, 2020)
2013 Employee Stock Purchase Plan, as amended (Filed With SEC on March 3, 2020)
2013 Employee Stock Purchase Plan, as amended (Filed With SEC on July 30, 2019)
Capital on Demand Sales Agreement, dated June 28, 2019, by and between Infinity Pharmaceuticals, Inc. and JonesTrading Institutional Services LLC (Filed With SEC on June 28, 2019)
Purchase and Sale Agreement, dated as of March 5, 2019, between the Registrant and HealthCare Royalty Partners III, L.P (Filed With SEC on May 7, 2019)
Protective Rights Agreement, dated as of March 11, 2019, between the Registrant and HCR Collateral Managements, LLC (Filed With SEC on May 7, 2019)